Table 3.
Overall (N = 83) | Before intervention | Short-term follow-up | Long-term follow-up | P-value before versus short | P-value before versus long |
---|---|---|---|---|---|
Positive effect last intervention (%) | – | 76.9 | 69.0 | – | – |
VAS score (0–100), median (IQR) | 60 (50–80) | 20 (0–50) | 40 (10–60) | <0.001 | <0.001 |
Defined daily dose nonopioids, mean ± SD | 1.2 ± 0.4 | 0.8 ± 0.7 | 0.4 ± 0.7 | 0.001 | 0.001 |
Defined daily dose opioids, mean ± SD | 0.4 ± 0.4 | 0.1 ± 0.2 | 0.1 ± 0.2 | 0.01 | 0.01 |
Physical component score (0–100), mean ± SD | 59 ± 22 | 61 ± 23 | 63 ± 24 | 0.5 | 0.4 |
Mental component score (0–100), mean ± SD | 67 ± 20 | 64 ± 21 | 71 ± 17 | 0.3 | 0.03 |
PHQ-9 score (0–27), median (IQR) | 9 (6–15) | 8 (4–13) | 6 (3–11) | 0.5 | 0.001 |